Clinical Trial Update: RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir [Phase 4]

View source ↗

Summary

The RELIEF Phase 4 trial compared episodic therapy to long-term suppression with famciclovir in recurrent genital herpes and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• Famvir (famciclovir)

Snippet

Sponsor: Novartis | Conditions: Recurrent Genital Herpes (RGH) | Phase 4 | Status: COMPLETED